Ricardo Escarcena
University of Salamanca
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ricardo Escarcena.
Pharmacological Reports | 2010
Fátima de Campos Buzzi; Mauricio Fracasso; Valdir Cechinel Filho; Ricardo Escarcena; Esther del Olmo; Arturo San Feliciano
The main objective of this study was to evaluate the antinociceptive activity of three ethylenediamine derivatives and three β-aminoethanol lipidic derivatives structurally related to dihydrosphingosine. These derivatives were selected on the basis of previous results from in vitro and in vivo anti-inflammatory studies. For all of the assayed compounds, an intraperitoneal dose of 3 mg/kg caused pronounced pain inhibition as measured by the acetic acid-induced writhing model in mice. Compounds 3 and 6 demonstrated strong antinociceptive activity at doses as low as 1 mg/kg and proved to be considerably more potent than the common nonsteroidal anti-inflammatory drugs (NSAIDs), acetylsalicylic acid (ASA) and acetaminophen (ACE). We further analyzed these compounds using the capsaicin- and glutamate-induced pain tests. Compounds 3 and 6 also exhibited considerable antinociceptive effects under these conditions, but their inhibitory effects in the formalin test were less pronounced. The exact mechanism of action for these compounds has yet to be established. However, based the results from a hot-plate test, it can be stated that these new drugs do not interact with the opioid system.
Bioorganic & Medicinal Chemistry Letters | 2009
Esther del Olmo; Gloria María Molina-Salinas; Ricardo Escarcena; Mario Alves; José L. López-Pérez; Rogelio Hernandez-Pando; Salvador Said-Fernández; Arturo San Feliciano
Fifteen dihydrosphingosine analogues have been synthesized and tested in vitro against Mycobacterium tuberculosis (MTB). Two ether (3 and 4b) and one diamine (8b) derivatives have displayed high mycobactericidal potency, with similar MIC values of 1.25 microg/mL, against the virulent strain H37Rv, as well as against a clinical isolate resistant to the five first-line anti-TB drugs. The three compounds, tested on other eleven cultured MTB strains with different multi-drug-resistance (MDR) patterns, retained their MIC values for most strains, or even lowered it, as in the case of compound 4b, which, assayed on strain No. 332, also resistant to all first-line anti-TB drugs, attained the MIC value of 0.78 microg/mL.
Tetrahedron | 1995
Julio G. Urones; David Díez; Isidro S. Marcos; Pilar Basabe; Anna M. Lithgow; Rosalina F. Moro; Narciso M. Garrido; Ricardo Escarcena
Abstract The right hand fragment, 36, of Usneoidone E, 1, a powerful antiviral and antitumoural agent has been synthesized from the β-pyrone 32. Using linalool as starting material, a 2,2,6,6-tetrasubstituted dihydropyrane 20, precursor of 32 and 33, was prepared. 20 was also synthesized from geranyl acetate through selenide 7, and is a versatile precursor for the synthesis of tetraprenyltoluquinols. Unambiguous 13C NMR assignment has been done by 2D correlations.
Bioorganic & Medicinal Chemistry | 2012
Jonathan Pérez-Meseguer; Esther del Olmo; Blanca Alanis-Garza; Ricardo Escarcena; Elvira Garza-González; Ricardo Salazar-Aranda; Arturo San Feliciano; Noemí Waksman de Torres
Twenty-five derivatives of the natural diterpene leubethanol, including several potential pro-drugs, with changes in the functionality of the aliphatic chain or modifications of the phenolic group, were synthesized and tested in vitro by the MABA technique for their activity against the H37Rv strain of Mycobacterium tuberculosis. Several compounds showed antimycobacterial potencies similar to that of the lead compound and two of them displayed higher selectivity indexes.
Bioorganic & Medicinal Chemistry Letters | 2012
Esther del Olmo; Rosario Diaz-Gonzalez; Ricardo Escarcena; Luis Carvalho; Luis A. Bustos; Miguel Navarro; Arturo San Feliciano
Twenty compounds selected as representative members of three series of long-chain 1,2-diamines, 2-amino-1-alkanols and 1-amino-2-alkanols structurally related to dihydrosphingosin, were synthesized and tested in vitro for their ability to inhibit the sleeping sickness parasites Trypanosoma bruceirhodesiense and Trypanosoma brucei gambiense. Eight compounds showed EC(50) values in the submicromolar range, with selectivity indexes up to 39 related to the respective cytotoxicity values for Vero cells. The parasite phenotype detected after treatment with the most potent compounds showed irreversible cell morphology alterations of the flagellar pocket that lead to inhibition of cell growth and parasite death.
Molecules | 2015
Ricardo Escarcena; Jonathan Pérez-Meseguer; Esther del Olmo; Blanca Alanis-Garza; Elvira Garza-González; Ricardo Salazar-Aranda; Noemí Waksman de Torres
Seventeen new derivatives of the natural diterpene leubethanol, including some potential pro-drugs, with changes in the functionality of the aliphatic chain or modifications of aromatic ring and the phenolic group, were synthesized and tested in vitro by the MABA technique for their activity against the H37Rv strain of Mycobacterium tuberculosis. Some compounds showed antimycobacterial selectivity indices higher than leubethanol.
Molecules | 2015
Ana L. Legarda-Ceballos; Esther del Olmo; Julio López-Abán; Ricardo Escarcena; Luis A. Bustos; Cristina Fonseca-Berzal; Alicia Gómez-Barrio; Juan Carlos Dib; Arturo San Feliciano; Antonio Muro
Thirteen aminoalcohols and eight diamines were obtained and tested against Trypanosoma cruzi epimastigotes strains MG, JEM and CL-B5 clone. Some of them were equal or more potent (1.0–6.6 times) than the reference compound nifurtimox. From them, three aminoalcohols and two diamines were selected for amastigotes assays. Compound 5 was as potent as the reference drug nifurtimox against amastigotes of the CL-B5 strain (IC50 = 0.6 µM), with a selectivity index of 54.
Antimicrobial Agents and Chemotherapy | 2015
María Ángeles Abengózar; Luis A. Bustos; Raquel García-Hernández; Pilar Fernández de Palencia; Ricardo Escarcena; Santiago Castanys; Esther del Olmo; Francisco Gamarro; Arturo San Feliciano; Luis Rivas
ABSTRACT Leishmaniasis is the protozoan disease second in importance for human health, superseded only by malaria; however, the options for chemotherapeutic treatment are increasingly limited due to drug resistance and toxicity. Under this perspective, a quest for new chemical compounds is urgently needed. An N-substituted 2-aminoalkan-1-ol scaffold has been shown to be a versatile scaffold for antiparasitic activity. Knowledge about its mechanism of action is still rather limited. In this work, we endeavored to define the leishmanicidal profile of such β-amino alkanol derivatives using a set of 15 N-mono- and disubstituted surrogates, tested on Leishmania donovani promastigotes and intracellular amastigotes. The best compound (compound 5), 2-ethylaminododecan-1-ol, had a 50% effective concentration (EC50) of 0.3 μM and a selectivity index of 72 for infected THP-1 cells and was selected for further elucidation of its leishmanicidal mechanism. It induced fast depletion of intracellular ATP content in promastigotes in the absence of vital dye intracellular entry, ruling out plasma membrane permeabilization as its origin. Confocal and transmission electron microscopy analyses showed that compound 5 induced severe mitochondrial swelling and vesiculation. Polarographic analysis using an oxygen electrode demonstrated that complex II of the respiratory chain (succinate reductase) was strongly inhibited by compound 5, identifying this complex as one of the primary targets. Furthermore, for other β-amino alkanols whose structures differed subtly from that of compound 5, plasma membrane permeabilization or interference with membrane traffic was also observed. In all, N-substituted β-amino alkanols were shown as appealing leishmanicidal candidates deserving further exploration.
Pharmacological Reports | 2018
Felipe J. Cavichioli; Graylin N.B. Bernal; Iandra Holzmann; Juliana Bagatini Klein; Ricardo Escarcena; Esther del Olmo; Arturo San Feliciano; Valdir Cechinel Filho; Nara Lins Meira Quintão
BACKGROUND The study evaluated the effects of two sphingosine derivatives N-(2-tert-butoxycarbamylhexadecyl)glutaramide (AA) and N-(1-benzyloxyhexadec-2-yl)glutaramide (OA) in different models of hypersensitivity in mice. METHODS Male Swiss mice were orally pre-treated with AA or OA (0.3-3mg/kg). After 1h, they received λ-carrageenan (300μg/paw), lipopolysaccharide (LPS; 100ng/paw), bradykinin (BK; 500ng/paw) or prostaglandin E2 (PGE2; 0.1nmol/paw) or epinephrine (100ng/paw), and the mechanical withdrawal thresholds were evaluated using von Frey filament (0.6g) at different time points. The effect of the compounds against inflammatory and neuropathic pain was also evaluated using complete Freunds adjuvant (CFA), or by performing partial sciatic nerve ligation (PSNL). RESULTS Animals pre-treated with AA and OA reduced hypersensitivity induced by carrageenan, LPS and BK, and modest inhibition of PGE2-induced hypersensitivity and carrageenan-induced paw oedema were observed in mice treated with OA. Though the partial effect presented by AA and OA, when dosed once a day, both compounds were able to significantly reduce the persistent inflammatory and neuropathic pain induced by CFA and PSNL, respectively. CONCLUSION These results demonstrate that the sphingosine derivatives AA and OA present important anti-hypersensitive effects, suggesting a possible interaction with the kinin signalling pathway. This may represent an interesting tool for the management of acute and chronic pain, with good bioavailability and safety.
Phytomedicine | 2008
Luis M. Bedoya; Amparo Álvarez; Mercedes Bermejo; Nuria González; Manuela Beltrán; Sonsoles Sánchez-Palomino; Sully M. Cruz; Isabel Gaitán; Esther del Olmo; Ricardo Escarcena; Pablo A. García; Armando Cáceres; Arturo San Feliciano; José Alcamí